Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05594251 · ClinicalTrials.gov registry record

Early Detection of Endotheliopathy Post-Transplant

A clinical trial, sponsored by St. Jude Children's Research Hospital.

Terminated
Registry status
32
Enrollment target

NCT05594251 is a clinical trial that was terminated before completion, run by St. Jude Children's Research Hospital. The registered enrollment target is 32 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05594251 was terminated before completion, sponsored by St. Jude Children's Research Hospital.

TERMINATED
Registry status
32 participants
Enrollment target

Study Summary

The goal of this research study is to learn more about possible risk factors that might be associated with side effects from stem cell transplants in people between the ages of 0 to 26 years old. Specifically, this study is looking at complications that arise from injury to the endothelium, a small layer of cells lining the blood vessels and heart. These complications can affect the heart, lungs, liver, kidneys and intestines and increase risk of severe illness needing care in the intensive care unit.

Trial Details

FieldValue
Enrollment Target 32 participants
Start Date 2022-11-28
Est. Completion 2024-05-05

What the Registry Record Tells You About NCT05594251

The ClinicalTrials.gov registry entry for NCT05594251 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is St. Jude Children's Research Hospital, which has 410 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT05594251 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05594251 about?

NCT05594251 is a clinical study titled "Early Detection of Endotheliopathy Post-Transplant". The goal of this research study is to learn more about possible risk factors that might be associated with side effects from stem cell transplants in people between the ages of 0 to 26 years old. Specifically, this study is looking at complications that arise from injury to the endothelium, a small ...

What is the current status of trial NCT05594251?

This trial is currently terminated. The enrollment target is 32 participants. The study started on 2022-11-28. Estimated completion is 2024-05-05.

Who is sponsoring clinical trial NCT05594251?

This trial is sponsored by St. Jude Children's Research Hospital, which has 410 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.